Whats New

2021.02.18

  1. paper

Clinical efficacy and safety of first-line nilotinib therapy and evaluation of the clinical utility of the FRET-based drug sensitivity test. Kondo T, et al, Int. J. Hematol.110(4): 482-489, 2019

For more details, click here.

ARCHIVE

2025
  1. 7
  2. 5
  3. 4
  4. 3
  5. 2
  6. 1
2024
  1. 12
  2. 11
  3. 10
  4. 8
  5. 7
  6. 6
  7. 5
  8. 4
  9. 3
  10. 1
2023
  1. 12
  2. 11
  3. 10
  4. 9
  5. 8
  6. 7
  7. 6
  8. 4
  9. 3
  10. 2
  11. 1
2022
  1. 11
  2. 10
  3. 9
  4. 7
  5. 6
  6. 5
  7. 4
  8. 3
  9. 2
  10. 1
2021
  1. 12
  2. 11
  3. 8
  4. 5
  5. 3
  6. 2
2020
  1. 10